357
Views
4
CrossRef citations to date
0
Altmetric
Psoriasis and phototherapy

Insight into psoriasis management: Commercial perspectives for the U.S. psoriasis market

&
Pages 18-26 | Received 13 Oct 2009, Accepted 13 Oct 2009, Published online: 09 Jun 2010

References

  • Van Voorhees AS, Fried R. Depression and quality of life in psoriasis. Postgrad Med. 2009;121(4):154–161.
  • Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc. 2004;9(2):136–139.
  • Feldman SR, Fleischer AB Jr, Cooper JZ. New topical treatments change the pattern of treatment of psoriasis: Dermatologists remain the primary providers of this care. Int J Dermatol. 2000;39(1):41–44.
  • McCarthy GM, Lamb GC, Russell TJ, Young MJ. Primary care-based dermatology practice: Internists need more training. J Gen Intern Med. 1991;6(1):52–56.
  • Kinney MA, Feldman SR. What's new in the management of psoriasis? G Ital Dermatol Venereol. 2009;144(2):103–117.
  • Berth-Jones J, Hutchinson PE. Vitamin D analogues and psoriasis. Br J Dermatol. 1992;127(2):71–78.
  • Bansback N, Sizto S, Sun H, Feldman S, Willian MK, Anis A. Efficacy of systemic treatments for moderate to severe plaque psoriasis: Systematic review and meta-analysis. Dermatology. 2009;219(3):209–218.
  • Fleischer AB Jr, Feldman SR, Rapp SR, Reboussin DM, Exum ML, Clark AR, Disease severity measures in a population of psoriasis patients: The symptoms of psoriasis correlate with self-administered psoriasis area severity index scores. J Invest Dermatol. 1996;107(1):26–29.
  • Kavanaugh A, McInnes I, Mease P, Krueger GG, Gladman D, Gomez-Reino J, Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheum. 2009;60(4):976–986.
  • Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med. 2005;11(1):43–49.
  • Wippel-Slupetzky K, Stingl G. Future perspectives in the treatment of psoriasis. Curr Probl Dermatol. 2009;38:172–189.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.